A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung Cancer

Clinical trial NCT05242965 · RECRUITING

Trial details

NCT number: NCT05242965
Sponsor: University of Washington
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Non-Small Cell Carcinoma Stage IV Lung Cancer AJCC v8

Start date: 2023-03-24
Primary completion: 2027-11-21
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.